Haploidentical transplantation in high‐risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow …

A Pérez‐Martínez, C Ferreras, A Pascual… - American Journal of …, 2020 - Wiley Online Library
A total of 192 pediatric patients, median age 8.6 years, with high‐risk hematological
malignancies, underwent haploidentical stem cell transplantation (haplo‐HSCT) using post …

[HTML][HTML] Improved outcome of refractory/relapsed acute myeloid leukemia after post-transplantation cyclophosphamide-based haploidentical transplantation with …

SR Jaiswal, S Zaman, A Chakrabarti, S Sen… - Biology of Blood and …, 2016 - Elsevier
We carried out post-transplantation cyclophosphamide (PTCy)-based haploidentical
peripheral blood stem cell transplantation in 51 patients with refractory/relapsed acute …

Abatacept and T-cell costimulation blockade—shifting the paradigm in the prevention of graft-versus-host disease

S Chakrabarti, SR Jaiswal - Frontiers in Hematology, 2023 - frontiersin.org
Despite advances in transplantation techniques and immunosuppressive therapies, graft-
versus-host disease (GVHD) remains a significant cause of morbidity and mortality …

[HTML][HTML] Favorable outcome of post-transplantation cyclophosphamide haploidentical peripheral blood stem cell transplantation with targeted busulfan-based …

KT Hong, HJ Kang, JY Choi, CR Hong… - Biology of Blood and …, 2018 - Elsevier
Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post-
transplantation cyclophosphamide (PTCy) was performed previously in adults using a …

Haploidentical stem cell transplantation with post-transplant cyclophosphamide for pediatric acute leukemia is safe and effective

A Sharma, N Rastogi, G Chatterjee… - Journal of Pediatric …, 2021 - journals.lww.com
Background: Haploidentical family donor is universally available and is fast emerging as an
alternative donor choice for children with leukemia needing hematopoietic stem cell …

Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for …

M Hu, J Li, T Hu, Z Zhang, S Feng, L Xuan… - Leukemia & …, 2024 - Taylor & Francis
This retrospective analysis evaluated the use of anti-thymocyte globulin (ATG) with or
without post-transplantation cyclophosphamide (PTCy) for graft-versus-host disease (GvHD) …

Antithymocyte Globulin Plus Post-Transplant Cyclophosphamide Combination as an Effective Strategy for Graft-versus-Host Disease Prevention in Haploidentical …

KH Wu, TF Weng, JP Li, YH Chao - Pharmaceuticals, 2022 - mdpi.com
Haploidentical hematopoietic stem cell transplantation using post-transplant
cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis has emerged …

Trasplante de células madre hematopoyéticas en pacientes pediátricos con diagnóstico de neoplasias mieloides, experiencia en 15 años

D Medina, L Gonzales, D Davalos, M Rosales… - Revista Colombiana de …, 2018 - Elsevier
Objetivo Describir la experiencia en términos de supervivencia y complicaciones de los
pacientes llevados a trasplante de células madre hematopoyéticos (TCMH) en los últimos …

Haploidentical Transplantation: Challenges and Solutions

S Chakrabarti, SR Jaiswal - Contemporary Bone Marrow Transplantation, 2021 - Springer
In the last few years, haploidentical family donor (HFD) has emerged as a front-runner for
alternate donor hematopoietic cell transplantation (HCT) in hematological malignancies …

[PDF][PDF] Haploidentical Stem Cell Transplantation

A Iqbal - ACADEMIC - researchgate.net
REVIEW OF LITERATURE: Haploidentical SCT is defined as transplantation of stem cells
that involves partially mismatched HLA antigens between recipient and donor, and atleast 1 …